A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.

Fiche publication

Date publication

mai 2023

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc , Dr MENEVEAU Nathalie , Dr CURTIT Elsa , Dr MANSI Laura , Dr VERNEREY Dewi , Dr MOUGIN-GUILLAUME Fabienne , Dr JACQUINOT Quentin

Tous les auteurs :
Drozd C, Curtit E, Jacquinot Q, Marquine C, Mansi L, Chaigneau L, Dobi E, Viot J, Meynard G, Paillard MJ, Goujon M, Roux P, Vernerey D, Gillet V, Bourdin H, Galli S, Meneveau N, Mougin F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37198562

Résumé

Up to 70% of breast cancer patients report symptoms of insomnia during and after treatment. Despite the ubiquity of insomnia symptoms, they are under-screened, under-diagnosed and poorly managed in breast cancer patients. Sleep medications treat symptoms but are ineffective to cure insomnia. Other approaches such as cognitive behavioral therapy for insomnia, relaxation through yoga and mindfulness are often not available for patients and are complex to implement. An aerobic exercise program could be a promising treatment and a feasible option for insomnia management in breast cancer patients, but few studies have investigated the effects of such a program on insomnia.